Handwriting Analysis in Movement Disorders — HANDWRML  

Parkinson Disease Clinical Trial

Official title: Advanced Machine Learning Analysis of Handwriting in Patients With Movement Disorders

Status Recruiting

Clinical Trial Summary

Handwriting is a complex cognitive prowess that deteriorates in patients affected by neurodegenerative diseases, including movement disorders. More in detail, patients with Parkinson's disease (PD) may manifest prominent handwriting abnormalities which have been collectively identified as parkinsonian micrographia. MIcrographia may manifest at the onset of the disease and then worsens progressively with time. Previous techniques released to investigate micrographia in PD relied on perceptual analysis of simple tasks or were based on expensive technological tools, including tablets. However, handwriting can be promptly collected in an ecological scenario, through safe, cheap, and largely available tools. Also, the objective handwriting analysis through artificial intelligence would represent an innovative strategy even superior to previous techniques, since it allows for the analysis of large amounts of data. In this experimental project, the investigators apply a specific machine learning algorithm to analyze handwriting samples recorded in healthy controls and PD patients. The study aims to verify whether the technique proposed by the investigators would be able to detect parkinsonian micrographia objectively, monitor the evolution of handwriting abnormalities and assess the symptomatic improvement of handwriting following L-Dopa administration in PD patients.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Disease
• Movement Disorders
• Parkinson Disease

• NCT number: NCT05355480
• Study type: Observational
• Source: Neuromed IRCCS
• Contact: Antonio Suppa, MD
• Phone: +00390649914074
• Email: antonio.suppa@uniroma1.it
• Status: Recruiting
• Start date: December 1, 2022
• Completion date: December 31, 2023